Ki67 immunohistochemical staining showed a decreased percentage of proliferating (Ki67+) tumor cells after the administration of niraparib and DAHP (Figure 7(d)), suggesting that the combination of GCH1 inhibitors and niraparib potently reined back tumor growth. The gene discussed is MKI67; the disease is neoplasm.